2F-DCK (2-Fluorodeschloroketamine)

⚛️ 2F-DCK (2-Fluorodeschloroketamine)

Advanced Dissociative Research Compound
2F-DCK, or 2-Fluorodeschloroketamine, is a synthetic dissociative compound belonging to the arylcyclohexylamine class. Structurally related to ketamine and deschloroketamine (DCK), it has become a focal point in neuropharmacological and toxicological research due to its distinctive receptor interactions and dissociative characteristics.

Scientific Overview

2F-DCK functions primarily as an NMDA receptor antagonist, making it valuable for studying glutamatergic neurotransmission, dissociative mechanisms, and cognitive modulation. Its molecular structure provides insight into the structure–activity relationships (SAR) among fluorinated arylcyclohexylamines.
Reported research observations include:

⚙️ NMDA receptor modulation and inhibition

Altered sensory perception and dissociative response mechanisms

Applications in neurochemical and behavioral studies

These properties have made 2F-DCK a significant compound for researchers exploring the neural pathways underlying dissociation and anesthetic activity.

⚗️ Applications in Research

2F-DCK is utilized primarily for:

Pharmacological and receptor-binding profiling

Analytical reference calibration and forensic identification

Neurochemical and behavioral model studies

Researchers value 2F-DCK for its high analytical purity, reliable consistency, and performance under controlled laboratory conditions.

⚠️ Critical Safety Notice
STRICTLY FOR RESEARCH USE ONLY

Not for human or animal consumption

Not for medical, veterinary, or household use

For qualified laboratory and research professionals only

Appropriate laboratory safety procedures and handling protocols must be observed at all times.

✅ Why Choose 2F-DCK for Your Research

Premium research-grade purity

Consistent analytical performance

Trusted by laboratories and research institutions worldwide

Explore the frontier of arylcyclohexylamine research with 2F-DCK — where scientific precision meets neurochemical innovation.